François Guilhot, Jean-Pierre Lamagnère, Jean Luc Harousseau, Hervé Tilly, Philippe Casassus, Norbert Ifrah, Henri Rochant, Francis Bauters, Gerard Dine, Joseph Tanzer
{"title":"一项针对未经治疗的ph1阳性慢性髓性白血病患者的随机治疗方案的多中心研究:干扰素α -2b和羟基脲加或不加阿糖胞嘧啶,初步结果","authors":"François Guilhot, Jean-Pierre Lamagnère, Jean Luc Harousseau, Hervé Tilly, Philippe Casassus, Norbert Ifrah, Henri Rochant, Francis Bauters, Gerard Dine, Joseph Tanzer","doi":"10.1016/0277-5379(91)90561-Q","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11925,"journal":{"name":"European Journal of Cancer and Clinical Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1991-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0277-5379(91)90561-Q","citationCount":"6","resultStr":"{\"title\":\"A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph1-positive chronic myelogenous leukaemia: Interferon alfa-2b and hydroxyurea with or without cytosine arabinoside, preliminary results\",\"authors\":\"François Guilhot, Jean-Pierre Lamagnère, Jean Luc Harousseau, Hervé Tilly, Philippe Casassus, Norbert Ifrah, Henri Rochant, Francis Bauters, Gerard Dine, Joseph Tanzer\",\"doi\":\"10.1016/0277-5379(91)90561-Q\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11925,\"journal\":{\"name\":\"European Journal of Cancer and Clinical Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0277-5379(91)90561-Q\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer and Clinical Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/027753799190561Q\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer and Clinical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/027753799190561Q","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph1-positive chronic myelogenous leukaemia: Interferon alfa-2b and hydroxyurea with or without cytosine arabinoside, preliminary results